Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 21, 2016
This is the recording of the webinar on the latest WHO recommendations regarding shorter, cheaper treatment regimen for multi-drug resistant (MDR) TB patients. Accurate and early diagnosis along with shorter, cheaper and more effective treatment can help countries deliver on their promises to end TB by 2030 or earlier (Sustainable Development Goal 3.3).
Panel of experts included:
* Dr ID RUSEN, Senior Vice President (Research and Development), International Union Against TB and Lung Disease (The Union), who leads the TREAT TB initiative which coordinated the STREAM clinical trials for shortened MDR-TB treatment regimen
* Dr FUAD MIRZAYEV, Medical Officer, Laboratories, Diagnostics and Drug Resistance unit, WHO Global TB Programme
* Dr SUNIL KHAPARDE, Deputy Director General of Revised National TB Control Programme, Ministry of Health and Family Welfare, India